Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Go or no go? Abbvie, Roche and Kala await key decisions
EP Vantage
Fri, 07/26/19 - 11:04 am
Tags:
FDA, AbbVie, upadacatinib, Roche, Ignyta, entrectinib, Kala Pharmaceuticals, KPI-121, dry eye disease
AbbVie scraps an anti-tau study, and that may foretell more big trouble for a beleaguered Biogen
Endpoints
Fri, 07/26/19 - 11:00 am
Tags:
AbbVie, Biogen, anti-tau antibodies, ABBV-8E12, progressive supranuclear palsy
Among recent megamergers only AbbVie-Allergan looks like a winner: analyst
Fierce Pharma
Wed, 07/24/19 - 10:08 pm
Tags:
AbbVie, Allergan, M&A, diversification
FDA-approved Humira copycat from Merck, Samsung Bioepis will wait 4 years to launch
Endpoints
Wed, 07/24/19 - 10:07 am
Tags:
Merck, Samsung Bioepis, FDA, Humira, AbbVie, drug launches, biosimilars
Merck's biosimilar to AbbVie's Humira wins FDA approval
Reuters
Tue, 07/23/19 - 07:35 pm
Tags:
Merck, Hadlima, biosimilars, FDA, AbbVie, Humira
Myovant's uterine fibroid drug looks competitive in PhIII — but can they vanquish mighty AbbVie?
Endpoints
Tue, 07/23/19 - 10:05 am
Tags:
Myovant, uterine fibroids, Relugolix, AbbVie, Elagolix
Biogen, Celgene, Bristol-Myers and AbbVie report earnings this week: Here’s what to expect
Marketwatch
Mon, 07/22/19 - 10:15 am
Tags:
Celgene, Biogen, AbbVie, Bristol-Myers Squibb, earnings
8 More Big Pharma Events in 2019 You Don't Want to Miss
Motley Fool
Mon, 07/22/19 - 09:44 am
Tags:
Novartis, Pfizer, AbbVie, Bristol-Myers Squibb, Merck, GSK
AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?
Yahoo/Zacks.com
Sat, 07/20/19 - 08:19 pm
Tags:
AbbVie, earnings
AbbVie jumps into STING cancer work with Mavupharma buy
Fierce Biotech
Mon, 07/15/19 - 10:55 am
Tags:
AbbVie, Mavupharma, M&A, STING, immuno-oncology
NICE recommends funding for psoriasis and type 1 diabetes drugs
Pharmaforum
Fri, 07/12/19 - 12:14 pm
Tags:
NICE, UK, NHS, AbbVie, Skyrizi, AstraZeneca, Farxiga
Pfizer's Xeljanz drops off top June TV spenders list—and Gilead's Biktarvy fills the void
Fierce Pharma
Thu, 07/11/19 - 09:45 am
Tags:
AbbVie, Humira, Gilead Sciences, Biktarvy, Truvada, Pfizer, Xeljanz, television ads, DTC ads
Why AbbVie's Stock Sank in the First Half of 2019
Motley Fool
Fri, 07/5/19 - 01:51 pm
Tags:
AbbVie, Humira, biosimilars, M&A, Allergan
Watch out AbbVie: Gilead is fast on your heels at the FDA with rival JAK inhibitor filgotinib
Endpoints
Tue, 07/2/19 - 10:46 am
Tags:
Gilead Sciences, AbbVie, FDA, JAK inhibitors, filgotinib, Upadacitinib, rheumatoid arthritis
Are AbbVie and Allergan Really Better Together?
Motley Fool
Fri, 06/28/19 - 12:23 pm
Tags:
AbbVie, Allergan, M&A
AbbVie deal for Allergan not about the taxes thanks to 2017 law
Biopharma Dive
Thu, 06/27/19 - 09:41 am
Tags:
Allergan, AbbVie, M&A, taxes
5 reasons AbbVie bought Allergan, and why they may not be enough
Biopharma Dive
Wed, 06/26/19 - 04:57 pm
Tags:
AbbVie, Allergan, M&A, Humira, Botox, cash, diversification
Top analyst finds a silver lining in AbbVie’s $63B Allergan buyout — but there’s a catch
Endpoints
Wed, 06/26/19 - 11:51 am
Tags:
AbbVie, Allergan, M&A, R&D, layoffs
Here's Why Nobody's Happy About This $63 Billion Buyout
Motley Fool
Wed, 06/26/19 - 10:41 am
Tags:
AbbVie, Allergan, M&A
How Brent Saunders’ Allergan experiment failed
Stat
Wed, 06/26/19 - 10:12 am
Tags:
Brent Saunders, Allergan, AbbVie, Pharma CEOs

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.